Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1

Shinjiro Maruyama, Taiki Akasaka, Koji Yamada, Hirofumi Tachibana

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Protein-bound polysaccharide-K (PSK) prepared from the basidiomycete Coriolus versicolor has been used as a biological response modifier for the treatment of cancer patients. Many studies describing the immunomodulatory effects and direct anti-cancer effects of PSK have been reported. Most of studies describing the immunomodulatory effects focused on cellular immunity, although there were several studies which focused on humoral immunity where PSK was shown to be able to induce antibody production in vivo. However, even in these humoral immunity studies, it is thought that the enhancement of antibody production was due to the activation of cellular immunity. In this study, we investigated the direct effect of PSK on B cells and discovered that PSK was able to enhance IgM production in the human B cell line BALL-1. Furthermore, BALL-1 was shown to have the characteristic features of B-1a cells, which are independently involved in the primary immune response. These results show that there is a possibility that PSK directly acts on B cells and simultaneously enhances both humoral immunity and cellular immunity.

Original languageEnglish
Pages (from-to)409-412
Number of pages4
JournalBiomedicine and Pharmacotherapy
Volume63
Issue number6
DOIs
Publication statusPublished - Jul 1 2009
Externally publishedYes

Fingerprint

Immunoglobulin M
B-Lymphocytes
Cell Line
Humoral Immunity
Cellular Immunity
Proteins
Antibody Formation
Immunologic Factors
Neoplasms
krestin
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1. / Maruyama, Shinjiro; Akasaka, Taiki; Yamada, Koji; Tachibana, Hirofumi.

In: Biomedicine and Pharmacotherapy, Vol. 63, No. 6, 01.07.2009, p. 409-412.

Research output: Contribution to journalArticle

@article{45c75975c2c94b4d9f30aa683ab97cf4,
title = "Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1",
abstract = "Protein-bound polysaccharide-K (PSK) prepared from the basidiomycete Coriolus versicolor has been used as a biological response modifier for the treatment of cancer patients. Many studies describing the immunomodulatory effects and direct anti-cancer effects of PSK have been reported. Most of studies describing the immunomodulatory effects focused on cellular immunity, although there were several studies which focused on humoral immunity where PSK was shown to be able to induce antibody production in vivo. However, even in these humoral immunity studies, it is thought that the enhancement of antibody production was due to the activation of cellular immunity. In this study, we investigated the direct effect of PSK on B cells and discovered that PSK was able to enhance IgM production in the human B cell line BALL-1. Furthermore, BALL-1 was shown to have the characteristic features of B-1a cells, which are independently involved in the primary immune response. These results show that there is a possibility that PSK directly acts on B cells and simultaneously enhances both humoral immunity and cellular immunity.",
author = "Shinjiro Maruyama and Taiki Akasaka and Koji Yamada and Hirofumi Tachibana",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.biopha.2008.08.006",
language = "English",
volume = "63",
pages = "409--412",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "6",

}

TY - JOUR

T1 - Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1

AU - Maruyama, Shinjiro

AU - Akasaka, Taiki

AU - Yamada, Koji

AU - Tachibana, Hirofumi

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Protein-bound polysaccharide-K (PSK) prepared from the basidiomycete Coriolus versicolor has been used as a biological response modifier for the treatment of cancer patients. Many studies describing the immunomodulatory effects and direct anti-cancer effects of PSK have been reported. Most of studies describing the immunomodulatory effects focused on cellular immunity, although there were several studies which focused on humoral immunity where PSK was shown to be able to induce antibody production in vivo. However, even in these humoral immunity studies, it is thought that the enhancement of antibody production was due to the activation of cellular immunity. In this study, we investigated the direct effect of PSK on B cells and discovered that PSK was able to enhance IgM production in the human B cell line BALL-1. Furthermore, BALL-1 was shown to have the characteristic features of B-1a cells, which are independently involved in the primary immune response. These results show that there is a possibility that PSK directly acts on B cells and simultaneously enhances both humoral immunity and cellular immunity.

AB - Protein-bound polysaccharide-K (PSK) prepared from the basidiomycete Coriolus versicolor has been used as a biological response modifier for the treatment of cancer patients. Many studies describing the immunomodulatory effects and direct anti-cancer effects of PSK have been reported. Most of studies describing the immunomodulatory effects focused on cellular immunity, although there were several studies which focused on humoral immunity where PSK was shown to be able to induce antibody production in vivo. However, even in these humoral immunity studies, it is thought that the enhancement of antibody production was due to the activation of cellular immunity. In this study, we investigated the direct effect of PSK on B cells and discovered that PSK was able to enhance IgM production in the human B cell line BALL-1. Furthermore, BALL-1 was shown to have the characteristic features of B-1a cells, which are independently involved in the primary immune response. These results show that there is a possibility that PSK directly acts on B cells and simultaneously enhances both humoral immunity and cellular immunity.

UR - http://www.scopus.com/inward/record.url?scp=68949090199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949090199&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2008.08.006

DO - 10.1016/j.biopha.2008.08.006

M3 - Article

C2 - 18848763

AN - SCOPUS:68949090199

VL - 63

SP - 409

EP - 412

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 6

ER -